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Abstract  
Detection of bacterial gene transcripts in low density mucosal samples is challenging. We 
evaluated the NanoString nCounter system for transcript detection in Neisseria meningitidis 
(Nm) cultures. The method was sensitive, reproducible (R2=0.99) and demonstrated changes 
in gene expression. Studying Nm transcripts from pharyngeal samples may be feasible using 
this approach.  
Text  
Neisseria meningitidis (Nm), the meningococcus, is a common commensal of the human 
pharynx that occasionally causes invasive disease. Primary prevention of meningococcal 
disease has relied, until recently, on polysaccharide conjugate vaccines. Novel protein-
antigen vaccines, Bexsero®, containing four main antigens fHbp, NadA, NHBA, and PorA 
(outer membrane vesicle), and Trumenba®, containing two fHbp variants have now become 
available. Detecting transcripts of established and candidate Nm vaccine proteins from 
pharyngeal samples of Nm carriers may help predict their potential value in inducing 
mucosal immune responses that could reduce carriage and transmission.  
Establishing an effective gene expression profiling platform in upper respiratory tract 
mucosal samples is particularly challenging due to the presence of both host mucosal cells 
and multiple bacterial species in the nasopharynx and because Nm is only present at low 
density in most pharyngeal carriers (1). The NanoString nCounter digital multiplexed gene 
detection and counting system has been shown to detect and quantify messenger RNA 
(mRNA) from low quantity samples accurately (2, 3). This method has previously been used 
to quantify mRNA transcripts directly in samples containing mixed bacteria using species-
specific nucleotides without the need for bacterial isolation, complementary DNA synthesis 
or amplification (4-6). We evaluated the performance of this system in detection and 
quantification of Nm mRNA transcripts in in vitro cultures of Nm. 
For a panel of 47 selected Nm genes, plus three housekeeping reference genes included for 
data normalisation, a codeset of 100 base length probes complementary to the gene target 
sequences was designed by NanoString, Seattle, Washington. Fifty bases were attached to a 
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biotin molecule, the capture probe, and the other 50 bases made up a reporter probe 
attached to colour coded fluorescent barcode specific to each gene assayed. One reporter 
count is equal to one transcript. The probes were designed to detect multiple isoforms of the 
selected Nm genes by targeting the conserved region of the genes, including those with 
known phase variability. They were not designed to identify the different variants of a gene. 
Genes were included that encode proteins in the meningococcal protein vaccines(7),  
candidate vaccine antigens identified from a literature search and proteins potentially 
involved in colonisation based on predicted surface expression (8-12). We included one gene 
likely to be involved in heat stress response, namely dsbA-2. 
 
Experiments were set up to measure differences in gene expression levels following 
incubation at different temperatures. A standard ATCC-BAA-335 Nm strain was cultured on 
Colombia blood agar (Oxoid) at 37°C for 16 hours in 5% CO2. Colonies were suspended in 
phosphate-buffered saline (PBS) with calcium and magnesium ions to OD600 1 and inoculated 
in 1:100 dilution into three tubes each containing 10ml brain heart infusion supplemented 
with 2% isovitalex (BD BBLTM) and 10% heat inactivated horse blood (TCS Biosciences). At 
mid-logarithmic phase (OD6000.5/ ~8x108cfu/ml), the liquid cultures were each split into 
three equal volumes and exposed to cold shock 26°C, heat shock 40°C or held at 37°C (as 
controls) for three hours, centrifuged at 5,000g for 2 minutes and re-suspended in 20μl 
RNase free PBS (PAA Laboratories). RNAlater was immediately added to the suspension, 
stored at 4°C overnight, and then frozen at -80°C.  
Prior to RNA extraction, samples were thawed on ice, diluted with an equal volume of ice cold 
PBS and centrifuged at 5000g for two minutes. Bacterial pellets were lysed with 15mg/ml 
lysozyme (Sigma) plus Tris-EDTA buffer, pH 8 for 30 minutes at room temperature in the 
presence of proteinase K (Sigma). Bacterial RNA was extracted using RNeasy mini kit following 
the manufacturer’s protocol; on-column DNase digestion was performed using RNase-free 
DNase set (Qiagen). RNA quality, quantity and integrity were assessed using the Nanodrop 
Denovix D-11+ Spectrophotometer and Agilent 2200 Tape station system.  
Aliquots of the extracts containing 100 ng/µl total RNA were run on the NanoString nCounter 
system. For the temperature experiments, one aliquot was taken from each of the three heat 
and cold shock samples, and two from each of the three 37°C control samples.  In addition, 
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to assess reproducibility and the lower limit of detection, 37°C samples were split into two 
technical replicates then diluted 4-fold to run samples of 100, 25, 6.25,1.56, 0.4, and 0.1 ng/μl 
total RNA. Two aliquots were run for each of the diluted samples for each replicate. Six 
positive and eight negative hybridisation controls were pre-mixed with the codeset during 
manufacturing. The assay followed the XT gene expression protocol (NanoString). A 5 µl 
sample of the extracted RNA sample was hybridised with a custom designed probeset at 65°C 
for 19 hours in a thermocycler. Post-hybridisation purification and digital readouts of the gene 
count were done using the automated prep-station and digital analyser. Assay quality control 
metrics such as field of view count, binding density and positive control linearity were 
assessed before analysis. Except for the serial dilution samples, the data were normalised 
using positive controls and the housekeeping genes on nSolver 3.0 software. The internal 
positive controls were synthetic primers designed by the external RNA control consortium 
(ERCC) to not be homologous to any known organism. They were pre-mixed into the codeset. 
Six positive controls were included in every assay. Housekeeping gene normalisation was 
done for heat and cold shock experiments to adjust gene counts relative to expression of 
three housekeeping genes (abcZ, adk and aroE) according to the NanoString data analysis 
guide (13).   
Statistical analysis was performed using Stata14 software. Multilevel mixed-effects linear 
regression was used to assess the relationship between gene expression and the different 
temperature conditions for the four vaccine genes, allowing for the multiple control 
samples. 
Serial dilution of RNA preparations demonstrated that gene expression signals could be 
detected from total RNA concentrations as low as 0.1 ng/μl (Table S1). There was a high 
degree of reproducibility between the means of the duplicates for the two technical 
replicates (Figure 1, R2=0.99).  
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Figure 1. Mean gene counts of Neisseria meningitidis for technical replicates 1 and 2 from 
100ng/µl total RNA.  
A wide range of expression of the 47 gene transcripts (up to 2.7-fold, Log2 fold changes) was 
observed after exposure to low and high temperatures vs. 37oC (Figure 2).  
 
 
(A) 
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(B)                   
 
Figure 2: Log2 fold change in gene expression across a panel of 47 genes showing up/down 
regulation of Neisseria meningitidis genes after (A) incubation at 26°C and (B) incubation at 
40°C. Vaccine genes are shown in red.  
 
After cold shock cysA, cysW and tonB showed the highest level of up-regulation, while after 
heat shock, porA, dsbA-2 and nadA showed most up-regulation.  For the vaccine genes, there 
was demonstrable down-regulation of nadA after cold shock, whereas after heat shock porA 
and nadA were upregulated and fhbP and nhbA were down-regulated (Table 1). 
Mean  
controls  Group  
Mean 
difference P value   [95% Conf. Interval] 
 
152732.3 
 
Cold shock vs Control porA  -13245.0 0.4 -44151.3 17661.2 
51152.9  fhbP -736.8 0.7 -4087.6 2614.1 
3440.4  nadA -404.3 0.003 -669.78 -138.9 
1218.6  nhbA -454.1 0.1 -991.29 83.1 
 Heat shock vs Control      
152732.3  porA  96803.4 0.001 65897.2 127709.7 
51152.9  fhbP -12401.9 0.001 -15752.8 -9051.2 
3440.4  nadA 712.0 0.001 446.6 972.4 
1218.6  nhbA -1416.8 0.001 -1954.0 -879.7 
Table 1:  Fold change in expression of Neisseria meningitidis genes encoding meningococcal 
vaccine proteins after incubation at 26°C (cold shock) and 40°C (heat shock) compared to 
incubation at 37°C.   
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Guckenberger et al (14), who used micro-arrays to measure Nm gene expression after heat 
shock at 45°C, had results consistent with those in our study, including for example, up-
regulation of dsbA-2 and down-regulation of pilO and genes involved in the ABC transport 
system (cysA, cysW, cysT in our panel). Interestingly, in our study, two of these genes (cysA, 
cysW) were up-regulated on cold exposure. 
This pilot study of gene expression profiling using a digital multiplexed gene detection system 
showed that mRNA can be detected and quantified from Nm cultures. The objective of this 
study was to assess the method (sensitivity, reproducibility, ability to detect fold change). The 
NanoString technique was highly reproducible, and we were able to detect transcripts from a 
very low quantity of total RNA. Application of this technique to Nm pharyngeal samples will 
be challenging as RNA concentrations in such samples will be relatively low, variation in levels 
of gene expression is wide, and RNA from other pharyngeal bacteria is likely to be present. 
For multi-copy genes, as our probes were targeted at conserved regions, a limitation is that we were 
unable to identify which copies were expressed, so these results should be interpreted with caution. 
Although the reliability of the NanoString platform has been extensively reported for other 
organisms (3-6, 15) , we plan to cross-validate our results with Nm with other methods such 
as reverse transcriptase qPCR for selected genes in subsequent experiments.  
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Highlights 
 N. meningitidis gene transcripts were quantified using NanoString technology for the 
first time. 
 The method was sensitive and reproducible. 
 Fold changes in gene expression were demonstrated after thermal stress. 
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